SignalXSignalX

IQVIA (IQV) Q3 2025 10-Q Quarterly Report

Filed: Oct 28, 2025Period ending Sep 30, 2025
Industrials
Services-Commercial Physical & Biological ResearchSEC EDGAR
IQVIA Overview

IQVIA (IQV) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 28, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

IQVIA Q3 2025 10-Q Analysis

Management Discussion & Analysis

  • • Revenue $4,100M Q3 2025, up 5.2% YoY ($204M increase); Technology & Analytics +$52M, R&D +$73M, Contract Sales +$25M
  • • Operating margin decreased: Segment profit $1,555M YTD, down 1.3% YoY ($21M); Technology & Analytics profit +1.6%, R&D profit -4.3%, Contract Sales profit +5.9%
  • • Best performing segment revenue growth: Contract Sales & Medical Solutions +16.1% Q3; Worst segment profit decline: Research & Development Solutions -0.4% Q3, -4.3% YTD
  • • Cash balance increased to $1,814M Sep 30, 2025 from $1,702M; Operating cash flow $1,919M YTD, up $88M YoY; repurchased 6.4M shares for $1,032M in 9 months
  • • Management expects sufficient liquidity for next 12 months; noted ongoing restructuring to reduce overcapacity; new $2B senior notes issued in June 2025; monitors tax changes and foreign currency impacts

Risk Factors

  • • No new or changed risk factors since 2024 Form 10-K
  • • Continued exposure to regulatory risks in global healthcare compliance
  • • Market risks persist from competitive pressures in contract research services
  • • Financial risk from debt maturity management as detailed in 2024 Form 10-K
  • • Liquidity risks and currency exposure remain key considerations

IQVIA Q3 2025 Quarterly Financials
XBRL

Revenue

$4.1B

▲ +5.2% YoY▲ +2.1% QoQ

Net Income

$331M

▲ +16.1% YoY▲ +24.4% QoQ

Operating Margin

13.5%

▼ -63bp YoY▲ +89bp QoQ

Net Margin

8.1%

▲ +76bp YoY▲ +145bp QoQ

ROE

5.4%

Total Assets

$28.7B

EPS (Diluted)

$1.92

▲ +23.9% YoY▲ +24.7% QoQ

Operating Cash Flow

$908M

▲ +25.9% YoY▲ +105.0% QoQ

Source: XBRL data from IQVIA Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other IQVIA Quarterly Reports

Q1 2025 10-Q

Get deeper insights on IQVIA

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.